Additionally, when the analysis was extended to low‐risk combined with favorable intermediate‐risk patients (N = 693) or low‐risk combined with all intermediate‐risk patients (N = 815), the results remained the same: There was no association between race and BCR (HR = 1.20; 95% CI = 0.79‐1.88; P = .36 or HR = 1.10; 95% CI = 0.75‐1.60; P = .62, respectively) and no association between predominate tumor location and BCR (HR = 1.10; 95% CI = 0.66‐1.78; P = .74 or HR = 0.91; 95% CI = 0.57‐1.43; P = .68, respectively). The gene discussed is BCR; the disease is neoplasm.